Making sense of rapidly evolving evidence on genetic associations is crucial to making genuine advances in human genomics
and the eventual integration of this information in the practice of medicine and public health. Assessment of the strengths
and weaknesses of this evidence, and hence the ability to synthesize it, has been limited by inadequate reporting of results.
The STrengthening the REporting of Genetic Association studies (STREGA) initiative builds on the Strengthening the Reporting
of Observational Studies in Epidemiology (STROBE) Statement and provides additions to 12 of the 22 items on the STROBE checklist.
The additions concern population stratification, genotyping errors, modeling haplotype variation, Hardy–Weinberg equilibrium,
replication, selection of participants, rationale for choice of genes and variants, treatment effects in studying quantitative
traits, statistical methods, relatedness, reporting of descriptive and outcome data, and the volume of data issues that are
important to consider in genetic association studies. The STREGA recommendations do not prescribe or dictate how a genetic
association study should be designed but seek to enhance the transparency of its reporting, regardless of choices made during
design, conduct, or analysis.
Keywords Gene-disease associations - Genetics - Gene-environment interaction - Systematic review - Meta-analysis - Reporting recommendations - Epidemiology - Genome-wide association
In order to encourage dissemination of the STREGA Statement, this article has also been published by Annals of Internal Medicine, European Journal of Clinical Investigation, European Journal of Epidemiology, Genetic Epidemiology,
Journal of Clinical Epidemiology, and PLoS Medicine. The authors jointly hold the copyright of this article.